Document is current

Article History

Received: 3 July 2023

Revised: 9 October 2023

Accepted: 16 October 2023

First Online: 15 November 2023

Declarations

:

: None. This is a clinical program description.

: This is a program description. This is a clinical practice setting that is being run in accordance with the rules set forth by the Food and Drug Administration. The ethics are covered with the contract each patient signs when patient in the clinical setting.

: Dr. Augostini receives a speaker honorarium from Zoll Respicardia for implant training. Meena Khan and Julie Mease declare no competing interests.